AbbVie

$110.64
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.61 (+1.48%) As of 4:31 PM UTC today

Why Robinhood?

You can buy or sell AbbVie and other stocks, options, and ETFs commission-free!

About ABBV

ABBVIE INC., also called AbbVie, is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions.

CEO

Richard A. Gonzalez

Employees

47,000

Headquarters

North Chicago, Illinois

Founded

2011

Market Cap

192.17B

Price-Earnings Ratio

39.88

Dividend Yield

4.46

Average Volume

7.19M

High Today

$111.44

Low Today

$109.40

Open Price

$109.64

Volume

2.90M

52 Week High

$113.41

52 Week Low

$79.11

ABBV News

BenzingaApr 15

Sound Mind Heads To Southern California For Third Annual Mental Health Music Festival On May 20

LOS ANGELES, April 15, 2021 /PRNewswire/ -- Today, Sound Mind Live announced the return of its annual SOUND MIND MENTAL HEALTH MUSIC FESTIVAL, which will take p

Analyst Ratings

74%

of 23 ratings

Buy

74%

Hold

26%

Sell

ABBV Earnings

$0.00

$0.97

$1.95

$2.92

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Available Apr 30, Pre-Market